Lung Cancer
News
Phase III vaccine trial halted
News
Immune therapy continues to advance in NSCLC
News
Ceritinib found safe and effective for NSCLC
Major finding: Oral ceritinib was found to be safe, with a maximum tolerated dose of 750 mg daily, and it elicited an overall tumor response rate...
News
Hormone therapy predicted improved lung cancer survival in women
Major Finding: Long-term hormone therapy was associated with significantly improved survival in women with non–small-cell lung cancer (HR, 0.54)....
News
Prior resection poses certain risks in lung transplantation
Major finding: Survival at 1 and 5 years was 83.6% and 48.4%, respectively, in the nonresection group, and 78.9% and 45.6% in the prior-resection...